CoChat

Anti‐interleukin‐6 monoclonal antibody induces regression of human prostate cancer xenografts in nude mice

Smith, Peter C., Keller, Evan T. · 2001 · The Prostate
Cited by 116

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Despite clinical associations and in vitro data suggesting that autocrine interleukin‐6 (IL‐6) production contributes to prostate cancer progression or chemotherapy resistance, there have been no reports that explore the role of IL‐6 on prostate tumors in vivo. In the present study, we investigated the effect of IL‐6 inhibition on the growth of human prostate cancer xenografts in nude mice. METHODS: To determine if autocrine IL‐6 production contributes to prostate cancer growth and chemotherapy resistance in vivo, xenografts of a human prostate cancer cell line that produces IL‐6 (PC‐3) were established in nude mice. The mice were randomly divided into four treatment groups: (1) saline (vehicle control) + murine IgG (isotype control); (2) etoposide + murine IgG; (3) saline + anti‐IL‐6 monoclonal antibody; and (4) etoposide + anti‐IL‐6 monoclonal antibody. Tumors were measured twice weekly during a 4‐week treatment period. At the conclusion of the study, all mice were sacrificed, and in addition to final volume, tumors were evaluated for the degree of apoptosis by TUNEL analysis. RESULTS: Anti‐IL‐6 Ab (with saline or etoposide) induced tumor apoptosis and regression (∼60% compared to initial tumor size). Etoposide alone did not induce tumor regression or apoptosis in this animal model, and there was no synergy between anti‐IL‐6 Ab and etoposide. CONCLUSIONS: These studies suggest that IL‐6 contributes to prostate cancer growth in vivo, and that targeting IL‐6 may contribute to prostate cancer therapy. Prostate 48:47–53, 2001. © 2001 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/pros.1080

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 116

Metadata

Authors
Smith, P. C., & Keller, E. T.
Venue
The Prostate
Publisher
Wiley
Published
2001-05-31
Volume
48
Issue
1
Pages
47-53
ISSN
  • 0270-4137 (ISSN-L)
  • 1097-0045
OpenAlex
W1979097970
Cited by
116
References
1
FWCI
6.34
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Anti‐interleukin‐6 monoclonal antibody induces regression of human prostate cancer xenografts in nude mice. https://app.cochat.ai/papers/10.1002/pros.1080
The paper
Smith, P. C., & Keller, E. T. (2001). Anti‐interleukin‐6 monoclonal antibody induces regression of human prostate cancer xenografts in nude mice. The Prostate. https://doi.org/10.1002/pros.1080

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.